Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome

• Status: Completed
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Metabolic syndrome: aetiology, pathogenesis, diagnosis, clinical management and prognosis

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Nazarbayev University; Republican Scientific Center for Emergency Medicine
• Collaborator: Institute Of Cardiology & Internal Diseases, Kazakhstan
• Treatments: Atorvastatin; Atorvastatin Calcium; Diltiazem; Orlistat

Criteria

Inclusion Criteria:

• written consent form

• age> 25 years

• skinfold thickness > 0,7 cm BP> 130/85 mm Hg or a patient on antihypertensive medications fasting blood glucose > 6.1 mmole/L, or 2-hour postprandial glucose level > 11.1 mmole/L / or a patient with type 2 diabetes blood cholesterol > 5.6 mmole/L possibility of treatment > 6 months follow-up > 1 year

Exclusion Criteria:

• complete immobilization of a patient (paresis /paralysis)

• patients with severe concomitant diseases of the kidneys and (or) of the liver

• early post-operative condition

• mental illness

• pregnancy

• persons who are in prison

• persons who are in military Armed Forces